• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Rises 1%; DermTech Shares Plummet

    6/18/24 12:08:00 PM ET
    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Telecommunications Equipment
    Telecommunications
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Get the next $ASNS alert in real time by email

    U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 0.1% on Tuesday.

    The Dow traded up 0.09% to 38,814.43 while the NASDAQ fell 0.01% to 17,855.89. The S&P 500 also rose, gaining, 0.19% to 5,483.50.

    Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 8% Dividend Yields

    Leading and Lagging Sectors

    Energy shares jumped by 0.7% on Tuesday.

    In trading on Tuesday, communication services shares fell by 0.7%.

    Top Headline

    U.S. industrial production increased 0.9% month-over-month in May, topping market estimates of a 0.3% gain.

    Equities Trading UP
                           

    • Reliance Global Group, Inc. (NASDAQ:RELI) shares shot up 258% to $0.7947 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.
    • Shares of Actelis Networks Inc (NASDAQ:ASNS) got a boost, surging 73% to $1.99 after the IoT solutions provider disclosed its partnership with Carahsoft, a leading U.S. IT Software and Services Company.
    • Comtech Telecommunications Corp (NASDAQ:CMTL) shares were also up, gaining 50% to $3.26 after the company announced a new $222 million credit facility.

    Equities Trading DOWN

    • Taysha Gene Therapies Inc (NASDAQ:TSHA) shares dropped 31% to $2.77 after the company announced longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial of TSHA-102 in Rett syndrome.
    • Shares of DermTech, Inc. (NASDAQ:DMTK) were down 58% to $0.14 after the company filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
    • Quantum Corporation (NASDAQ:QMCO) was down, falling 47% to $0.41 following weaker-than-expected FY 2024 results.

    Also Check This Out: How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings Report

    Commodities

    In commodity news, oil traded up 1.2% to $81.30 while gold traded up 0.6% at $2,342.40.

    Silver traded up 0.2% to $29.44 on Tuesday, while copper rose 0.3% to $4.4615.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 gained 0.69%, Germany's DAX rose 0.35% and France's CAC 40 gained 0.76%. Spain's IBEX 35 Index rose 0.99%, while London's FTSE 100 climbed 0.60%.

    Annual inflation rate in the Eurozone accelerated to 2.6% in May from 2.4% in the previous month, while ZEW Indicator of Economic Sentiment rose by 4.3 points to a reading of 51.3 in June.

    The ZEW Indicator of Economic Sentiment for Germany rose to 47.5 in June, notching the highest reading since February 2022.

    Asia Pacific Markets

    Asian markets closed mostly higher on Tuesday, with Japan's Nikkei gaining 1%, Hong Kong's Hang Seng Index declining 0.11%, China's Shanghai Composite Index gaining 0.48% and India's S&P BSE Sensex gaining 0.4%.

    Singapore’s non-oil domestic exports slipped 0.1% year-over-year for May versus a sharp 9.6% decline in the prior month.

    Economics

    • U.S. retail sales rose 0.1% month-over-month in May compared to a revised 0.2% declined in April and missing market expectations of 0.2% gain.
    • U.S. industrial production increased 0.9% month-over-month in May, topping market estimates of a 0.3% gain.

    Now Read This: $176M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying

    Get the next $ASNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASNS
    $CMTL
    $DMTK
    $QMCO

    CompanyDatePrice TargetRatingAnalyst
    Quantum Corporation
    $QMCO
    3/25/2026$8.00Buy
    Lake Street
    Quantum Corporation
    $QMCO
    11/14/2025Market Perform → Outperform
    Northland Capital
    Taysha Gene Therapies Inc.
    $TSHA
    10/21/2025$13.00Strong Buy
    Raymond James
    Taysha Gene Therapies Inc.
    $TSHA
    7/11/2025$8.00Buy
    BofA Securities
    Taysha Gene Therapies Inc.
    $TSHA
    6/27/2024$5.00Outperform
    BMO Capital Markets
    Comtech Telecommunications Corp.
    $CMTL
    6/25/2024$3.50Underperform → Hold
    Jefferies
    Taysha Gene Therapies Inc.
    $TSHA
    4/9/2024$9.00Overweight
    Piper Sandler
    Comtech Telecommunications Corp.
    $CMTL
    12/15/2023$18.25Buy
    B. Riley Securities
    More analyst ratings

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Nagendran Sukumar

    4 - Taysha Gene Therapies, Inc. (0001806310) (Issuer)

    4/13/26 4:33:58 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Nash Laura A.

    4 - QUANTUM CORP /DE/ (0000709283) (Issuer)

    4/3/26 4:15:38 PM ET
    $QMCO
    Electronic Components
    Technology

    SEC Form 4 filed by Meyrath Hugues

    4 - QUANTUM CORP /DE/ (0000709283) (Issuer)

    4/3/26 4:15:08 PM ET
    $QMCO
    Electronic Components
    Technology

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Manning Paul B bought $2,062,500 worth of shares (750,000 units at $2.75) (SEC Form 4)

    4 - Taysha Gene Therapies, Inc. (0001806310) (Issuer)

    6/3/25 9:38:27 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Manning Paul B bought $2,999,999 worth of shares (1,333,333 units at $2.25) (SEC Form 4)

    4 - Taysha Gene Therapies, Inc. (0001806310) (Issuer)

    7/1/24 8:00:07 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chairman and CEO Beyman Ezra was granted 249,000 shares, covered exercise/tax liability with 55,787 shares and bought $8,502 worth of shares (30,000 units at $0.28), increasing direct ownership by 73% to 527,100 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    6/28/24 6:10:12 AM ET
    $RELI
    Specialty Insurers
    Finance

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    SEC Filings

    View All

    SEC Form DEFA14A filed by Taysha Gene Therapies Inc.

    DEFA14A - Taysha Gene Therapies, Inc. (0001806310) (Filer)

    4/22/26 8:02:49 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Taysha Gene Therapies Inc.

    DEF 14A - Taysha Gene Therapies, Inc. (0001806310) (Filer)

    4/22/26 8:01:44 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Actelis Networks Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - ACTELIS NETWORKS INC (0001141284) (Filer)

    4/13/26 12:15:14 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Actelis Networks Secures New Order for Alaska State Department of Transportation Intelligent Transportation System Project

    Sunnyvale, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (OTC:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that it has received an order to supply its hybrid fiber-copper networking solution for an intelligent transportation system ("ITS") project for the Alaska State Department of Transportation. The order, placed through one of Actelis' long-standing partners, supports the modernization of traffic signal and cabinet infrastructure in the Anchorage area. "Our growing list of U.S. state,county and municipal transportation customers includes the State of A

    4/23/26 9:28:01 AM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    Quantum CatDV Showcases Automated Live Sports Production with North Shore Automation's Stats Injector

    Integration delivers real-time play-by-play metadata directly into media assets for professional sports organizations; Continues recent platform enhancements including expanded cloud, clustering, and AI capabilities Quantum Corporation (NASDAQ:QMCO) today announced that North Shore Automation's Stats Injector is now fully compatible with Quantum CatDV, the media asset management and workflow orchestration platform used by broadcasters, sports leagues, and post-production teams world-wide, bringing automated, data-driven clip logging to live sports production workflows. The integration, already deployed in production with the Miami HEAT, is designed to pull hyper-accurate play-by-play data

    4/17/26 10:49:00 AM ET
    $QMCO
    Electronic Components
    Technology

    Quantum Responds to Industry-Wide Supply Chain and Power Disruption Ahead of NAB 2026

    AI-Driven Infrastructure Pressure Makes Tape a Strategic Technology for Media Production and Enterprise Workflows: Quantum Brings "Shockproof Workflows" and Deep Technical Expertise to NAB Show Quantum Corporation (NASDAQ:QMCO) today highlighted its solutions designed to address AI-driven supply chain and power challenges arising from surging costs, constrained availability, and supply uncertainty for flash and hard disk technologies. Ahead of the 2026 NAB Show, Quantum is introducing "shockproof workflows," architectures intended to mitigate those vulnerabilities with available solutions that enable relief from energy constraints, lower storage costs, and support hardware-level cyber-res

    4/16/26 8:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Quantum with a new price target

    Lake Street resumed coverage of Quantum with a rating of Buy and set a new price target of $8.00

    3/25/26 8:49:51 AM ET
    $QMCO
    Electronic Components
    Technology

    Quantum upgraded by Northland Capital

    Northland Capital upgraded Quantum from Market Perform to Outperform

    11/14/25 12:04:07 PM ET
    $QMCO
    Electronic Components
    Technology

    Raymond James initiated coverage on Taysha Gene Therapies with a new price target

    Raymond James initiated coverage of Taysha Gene Therapies with a rating of Strong Buy and set a new price target of $13.00

    10/21/25 7:22:35 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Financials

    Live finance-specific insights

    View All

    Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

    Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ASPIRE trial in three patients aged 2 to <4 years with inclusion of ≥3 months of safety data in planned BLA submission to support potential for broad label; on track to complete dosing in Q2 2026 Maintained favorable tolerability profile with no treatment-related SAEs or DLTs in REVEAL Phase 1/2 and REVEAL pivotal trials as of March 2026 data cutoff; longer-term safety and efficacy data from Part A of REVEAL Phase 1/2 trials expected in Q2 2026 Reached written alignment with FDA on proposed PPQ

    3/19/26 8:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Comtech Announces Financial Results for Second Quarter of Fiscal 2026

    March 16, 2026-- Comtech Telecommunications Corp. (NASDAQ:CMTL) ("Comtech" or the "Company"), a global communications technology leader, today reported financial results for its second quarter ended January 31, 2026. Ken Traub, Chairman, President and CEO, stated: "Comtech continued on its positive trajectory of improvement, as we delivered our fourth consecutive quarter of positive operating cash flow and ended the quarter with approximately $50 million of total liquidity. With net bookings of $175 million in the quarter, we have achieved a book-to-bill ratio of 1.64x, increased our backlog to $732 million and maintained our revenue visibility at approximately $1.1 billion. As previous

    3/16/26 4:12:00 PM ET
    $CMTL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Comtech to Host Second Quarter Fiscal 2026 Earnings Conference Call on March 16, 2026

    March 12, 2026-- Comtech Telecommunications Corp. (NASDAQ:CMTL) ("Comtech" or the "Company"), a global communications technology leader, today announced that it plans to release its second quarter fiscal 2026 operating results after the market closes on Monday, March 16, 2026. At 4:30 p.m. ET that day, Comtech's leadership team will hold a conference call to discuss the Company's second quarter fiscal 2026 results, operations and business trends. A real-time webcast of the call will be available to the public at the investor relations section of the Comtech web site at www.comtech.com. Alternatively, investors can access the conference call by dialing (800) 225-9448 (primary) or (203) 518

    3/12/26 9:00:00 AM ET
    $CMTL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Appoints William H. White as Chief Financial Officer

    Seasoned finance executive brings growth-focused mindset to advancing Quantum's long-term strategy Quantum Corporation (NASDAQ:QMCO) today announced the appointment of William H. White as its Chief Financial Officer. White will lead Quantum's global finance organization, including financial strategy and operations, capital structure initiatives, and investor relations, supporting the company's next phase of growth and operational execution. White brings more than two decades of experience transforming technology companies through disciplined financial leadership and strategic capital allocation. He is recognized for improving operational rigor and modernizing reporting and forecasting p

    2/2/26 8:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    Comtech Appoints Mary Jane Raymond to its Board of Directors

    December 11, 2025-- Comtech Telecommunications Corp. (NASDAQ:CMTL) ("Comtech" or the "Company"), a global communications technology leader, today announced that its Board of Directors (the "Board") has appointed Mary Jane Raymond as an independent director, effective December 11, 2025. Following Ms. Raymond's appointment, the Board consists of eight directors. Ms. Raymond brings more than three decades of public company finance and governance experience. From 2014 through 2024, she served as Chief Financial Officer of Coherent Corp. (NYSE:COHR), formerly II-VI Incorporated, a global leader in engineered materials and optoelectronic components with revenue exceeding $5.8 billion. She previo

    12/11/25 4:48:00 PM ET
    $CMTL
    $COHR
    $VECO
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Electronic Components
    Industrial Machinery/Components

    Quantum Appoints Geoff Barrall as Chief Product Officer to Accelerate Innovation and Product Strategy

    Industry leader brings decades of storage experience to guide Quantum's technology roadmap and deliver solutions designed to meet data management requirements in the AI era Quantum Corporation (NASDAQ:QMCO) today announced the appointment of Geoff Barrall as the company's Chief Product Officer (CPO). A highly respected and widely recognized leader in enterprise storage and data management, Barrall will lead Quantum's product strategy, innovation, and engineering direction, strengthening the company's position as the trusted partner for managing every stage of the data lifecycle. "Geoff is a proven product and technology leader with a remarkable track record of founding companies, scalin

    10/7/25 10:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    $ASNS
    $CMTL
    $DMTK
    $QMCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Quantum Corporation

    SC 13G/A - QUANTUM CORP /DE/ (0000709283) (Subject)

    12/4/24 12:24:18 PM ET
    $QMCO
    Electronic Components
    Technology

    Amendment: SEC Form SC 13D/A filed by Comtech Telecommunications Corp.

    SC 13D/A - COMTECH TELECOMMUNICATIONS CORP /DE/ (0000023197) (Subject)

    11/18/24 5:30:12 PM ET
    $CMTL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Taysha Gene Therapies Inc.

    SC 13G/A - Taysha Gene Therapies, Inc. (0001806310) (Subject)

    11/14/24 5:51:11 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care